Biofil Chemicals and Pharmaceuticals Limited

NSE BIOFILCHEM.NS

Biofil Chemicals and Pharmaceuticals Limited EBITDA for the year ending March 31, 2024: USD 156.60 K

Biofil Chemicals and Pharmaceuticals Limited EBITDA is USD 156.60 K for the year ending March 31, 2024, a 1.78% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Biofil Chemicals and Pharmaceuticals Limited EBITDA for the year ending March 31, 2023 was USD 153.86 K, a -21.22% change year over year.
Biofil Chemicals and Pharmaceuticals Limited EBITDA for the year ending March 31, 2022 was USD 195.31 K, a -39.78% change year over year.
Biofil Chemicals and Pharmaceuticals Limited EBITDA for the year ending March 31, 2021 was USD 324.33 K, a 23.86% change year over year.
Biofil Chemicals and Pharmaceuticals Limited EBITDA for the year ending March 31, 2020 was USD 261.84 K, a 65.08% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

NSE: BIOFILCHEM.NS

Biofil Chemicals and Pharmaceuticals Limited

CEO	Mr. Ramesh S. Shah
IPO Date	July 27, 2017
Location	India
Headquarters	11/12, Sector "E"
Employees	26
Sector	Industrials
Industries Petrochemicals Chemicals & Advanced Materials Cleaning Supplies Cosmetics Fertilizers Personal Care Pharmaceuticals Plastics

Description

Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic dippers and caps. It also provides job work service for manufacturing of pharmaceuticals. The company was incorporated in 1985 and is based in Indore, India.

Key trends

Past 5 years